|
|
| | Birtamimab Basic information |
| Product Name: | Birtamimab | | Synonyms: | Birtamimab;Research Grade Birtamimab (DHC65501);Research Grade Birtamimab;Birtamimab (anti-Amyloid Alpha) | | CAS: | 1608108-91-3 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Birtamimab Structure]() |
| | Birtamimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Birtamimab Usage And Synthesis |
| Uses | Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis[1]. | | References | [1] AGertz M, et, al. Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design. Journal home page for Blood. Volume 138, Supplement 1, 23 November 2021, Page 2754. |
| | Birtamimab Preparation Products And Raw materials |
|